Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Naismith RT, Wolinsky JS, Wundes A, LaGanke C, et al. Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. Mult Scler 2019 Nov 4:1352458519881761. doi: 10.1177/1352458519881761.
PMID: 31680631


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016